Sabrina Badir
CEO
PA
Pregnolia AG
Pregnolia has developed a medical device that measures cervical tissue stiffness in both pregnant and non-pregnant women, providing healthcare providers with critical data for assessing cervical status. This technology enhances pregnancy care by enabling more accurate evaluations, which can inform clinical decisions related to the risk of premature birth.
- Hardware
- Healthcare Technology
- Medical Devices
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Current methods of assessing cervical status rely on subjective manual palpation, which can be unreliable in predicting the risk of premature birth. This subjectivity can lead to inconsistent evaluations and potentially impact clinical decisions during pregnancy.
Solution
Pregnolia has developed a medical device that quantitatively measures cervical tissue stiffness in pregnant women, providing healthcare providers with objective data to enhance pregnancy care. The Pregnolia system allows for a more complete characterization of cervical status, which can inform clinical decisions related to the risk of premature birth. By offering a precise measurement of cervical stiffness, the device aims to improve the accuracy of risk assessments compared to traditional methods.
Target Audience
The primary users are healthcare providers, specifically gynecologists and obstetricians, involved in pregnancy care and assessing the risk of premature birth.
Features
- Medical device for measuring cervical tissue stiffness
- Provides quantitative data on cervical status
- Aims to improve the accuracy of premature birth risk assessment
- CE certified and available in selected European markets